Colgate

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Colgate and other ETFs, options, and stocks.

About CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. 

CEO
Noel R. Wallace
CEONoel R. Wallace
Employees
33,600
Employees33,600
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1806
Founded1806
Employees
33,600
Employees33,600

CL Key Statistics

Market cap
77.43B
Market cap77.43B
Price-Earnings ratio
38.62
Price-Earnings ratio38.62
Dividend yield
2.13%
Dividend yield2.13%
Average volume
5.44M
Average volume5.44M
High today
$97.97
High today$97.97
Low today
$95.93
Low today$95.93
Open price
$97.11
Open price$97.11
Volume
2.70M
Volume2.70M
52 Week high
$101.81
52 Week high$101.81
52 Week low
$75.96
52 Week low$75.96

Stock Snapshot

The current Colgate(CL) stock price is $97.41, with a market capitalization of 77.43B. The stock trades at a price-to-earnings (P/E) ratio of 38.62 and offers a dividend yield of 2.13%.

On 2026-11-19, Colgate(CL) stock traded between a low of $95.93 and a high of $97.97. Shares are currently priced at $97.41, which is +1.5% above the low and -0.6% below the high.

Colgate(CL) shares are trading with a volume of 2.7M, against a daily average of 5.44M.

In the last year, Colgate(CL) shares hit a 52-week high of $101.81 and a 52-week low of $75.96.

In the last year, Colgate(CL) shares hit a 52-week high of $101.81 and a 52-week low of $75.96.

CL News

Investing.com 3d
Colgate Palmolive stock hits 52-week high at 101.19 USD - Investing.com

...

Colgate Palmolive stock hits 52-week high at 101.19 USD - Investing.com
The Motley Fool 4d
Colgate-Palmolive vs. Kimberly-Clark: Which Household Name Deserves Your Investment Dollars?

Investors often turn to reliable household brands when volatility hits the market. Choosing between Colgate-Palmolive (CL +1.81%) and Kimberly-Clark (KMB +2.09%...

Colgate-Palmolive vs. Kimberly-Clark: Which Household Name Deserves Your Investment Dollars?
Simply Wall St 5d
Colgate-Palmolive Rallies On Resilient Growth Narrative As Fair Value Debate Heats Up

Colgate-Palmolive (CL) has been back in focus after recent commentary highlighted its steady growth profile, rising dividend, and emphasis on oral care and pet...

Colgate-Palmolive Rallies On Resilient Growth Narrative As Fair Value Debate Heats Up

Analyst ratings

57%

of 23 ratings
Buy
56.5%
Hold
39.1%
Sell
4.3%

More CL News

The Motley Fool 6d
Celsius vs. Colgate-Palmolive: Which Consumer Goods Stock Is a Better Buy for 2027?

Should I buy the high-octane growth of Celsius (CELH +2.02%) or the steady, defensive reliability of Colgate-Palmolive (CL +1.59%)? Both companies command stron...

Celsius vs. Colgate-Palmolive: Which Consumer Goods Stock Is a Better Buy for 2027?
24/7 Wall St. 6d
What If the Fed Doubles the Rate Hike in December? These 5 Dividend Stocks Could Prosper

Investing What If the Fed Doubles the Rate Hike in December? These 5 Dividend Stocks Could Prosper By Lee Jackson 𝕏 f ⧉ Quick Read JPMorgan and PNC would widen...

What If the Fed Doubles the Rate Hike in December? These 5 Dividend Stocks Could Prosper

People also own

Based on the portfolios of people who own CL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.